OA06606A - Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée. - Google Patents

Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée.

Info

Publication number
OA06606A
OA06606A OA57119A OA57119A OA06606A OA 06606 A OA06606 A OA 06606A OA 57119 A OA57119 A OA 57119A OA 57119 A OA57119 A OA 57119A OA 06606 A OA06606 A OA 06606A
Authority
OA
OAPI
Prior art keywords
new derivatives
aminopropanesulfonic acid
membrane activity
enhanced membrane
enhanced
Prior art date
Application number
OA57119A
Other languages
English (en)
French (fr)
Inventor
Jean Pierre Durlach
Original Assignee
Meram Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meram Lab filed Critical Meram Lab
Publication of OA06606A publication Critical patent/OA06606A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA57119A 1979-05-23 1980-05-23 Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée. OA06606A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7913207A FR2457281A1 (fr) 1979-05-23 1979-05-23 Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Publications (1)

Publication Number Publication Date
OA06606A true OA06606A (fr) 1981-08-31

Family

ID=9225819

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57119A OA06606A (fr) 1979-05-23 1980-05-23 Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée.

Country Status (18)

Country Link
US (1) US4355043A (en])
JP (2) JPS5625146A (en])
AT (1) AT372371B (en])
AU (1) AU535785B2 (en])
BE (1) BE883468A (en])
CA (1) CA1152100A (en])
CH (1) CH647757A5 (en])
DE (2) DE19675017I2 (en])
ES (1) ES8101042A1 (en])
FR (1) FR2457281A1 (en])
GB (1) GB2051789B (en])
GR (1) GR68547B (en])
IT (1) IT1130455B (en])
MA (1) MA18855A1 (en])
MX (1) MX9203363A (en])
NL (2) NL191789C (en])
OA (1) OA06606A (en])
ZA (1) ZA803051B (en])

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193197B (en) * 1984-02-03 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Preparatives regulating the growth of plants containing as reagent derivatives of n-substituated amin-prophansulphonic acid and process for production of the reagent
JPH0725771B2 (ja) * 1992-06-18 1995-03-22 財団法人生産開発科学研究所 ２−アミノエタンスルホン酸亜鉛錯化合物
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
AU765522B2 (en) * 1998-01-13 2003-09-18 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
EP1051393B1 (fr) * 1998-01-27 2003-10-01 Merck Sante Nouveaux derives d'acides aminoalkane sulfoniques, phosphoniques et phosphiniques, leur preparation et leur utilisation comme medicaments
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
FR2775188B1 (fr) 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
DE60042896D1 (de) * 1999-04-28 2009-10-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
JP2008519822A (ja) * 2004-11-12 2008-06-12 ニューロケム （インターナショナル） リミテッド アミロイド関連疾患を治療するための方法およびフッ素化組成物
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
BRPI0519243A2 (pt) 2004-12-22 2009-01-06 Neurochem Int Ltd mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2007125385A2 (en) * 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
AU2007357451B2 (en) 2006-10-12 2012-11-15 Bhi Limited Partnership. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
WO2008078176A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
CA2703831C (en) * 2007-09-07 2013-04-16 Xenoport, Inc. Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090082464A1 (en) * 2007-09-07 2009-03-26 Bernd Jandeleit Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) * 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
CN101492400B (zh) * 2008-01-22 2014-03-12 北京华禧联合科技发展有限公司 一种高纯度阿坎酸钙的制备方法
DE102008048791A1 (de) 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato
CN104478766A (zh) * 2014-12-25 2015-04-01 北京华禧联合科技发展有限公司 一种制备高纯度乙酰基高牛磺酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039916A (en) * 1961-03-27 1962-06-19 West Laboratories Inc Anionic iodine complexes
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
JPS5418714B2 (en]) * 1974-10-08 1979-07-10
FR2321285A1 (fr) * 1975-08-18 1977-03-18 Stanley Drug Products Inc Agents antifibrinolytiques
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US4233229A (en) * 1978-01-03 1980-11-11 Gaf Corporation Preparation of salt-free N-acyl taurines

Also Published As

Publication number Publication date
JPH0524135B2 (en]) 1993-04-06
DE19675017I2 (de) 2001-04-26
CA1152100A (en) 1983-08-16
ES491787A0 (es) 1980-12-16
MX9203363A (es) 1992-07-01
MA18855A1 (fr) 1980-12-31
GB2051789B (en) 1983-04-27
NL191789B (nl) 1996-04-01
IT8067807A0 (it) 1980-05-22
AU535785B2 (en) 1984-04-05
JPS5625146A (en) 1981-03-10
JPH0317825B2 (en]) 1991-03-11
AU5869780A (en) 1980-11-27
ZA803051B (en) 1981-06-24
DE3019350C2 (en]) 1989-11-30
NL970003I2 (nl) 1997-08-01
ES8101042A1 (es) 1980-12-16
NL970003I1 (nl) 1997-04-01
BE883468A (fr) 1980-11-24
CH647757A5 (fr) 1985-02-15
GR68547B (en]) 1982-01-18
DE3019350A1 (de) 1980-12-04
US4355043A (en) 1982-10-19
ATA274580A (de) 1983-02-15
IT1130455B (it) 1986-06-11
NL191789C (nl) 1996-08-02
AT372371B (de) 1983-09-26
FR2457281B1 (en]) 1983-10-07
FR2457281A1 (fr) 1980-12-19
NL8002997A (nl) 1980-11-25
JPH03148219A (ja) 1991-06-25
GB2051789A (en) 1981-01-21

Similar Documents

Publication Publication Date Title
OA06606A (fr) Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée.
BE851306A (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique
BE860976A (fr) Solution stable contenant un acide percarboxylique
BE863429A (fr) Derives de l'acide quinoleine-carboxylique
OA05964A (fr) Dérivés de l, l-dioxyde d'acide pénicillanique.
OA05593A (fr) Nouveaux dérivés d'acide 4,5-dichlorimidazole-2- carboxylique, leur procédé de préparation et leur application comme pesticides.
BE822986A (fr) Nouveaux esters de pyrimidine d'acide thionothiolphosphorique
BE868287A (fr) Nouveaux derives de l'acide amidinopenicillanique
BE886370A (fr) Derives de l'acide 16-hydroxy-prostanoique 4,5-insatures
MA18782A1 (fr) Purification de l'acide phosphorique .
BE819640A (fr) Nouveaux derives de l'acide phenylbenzoique
FR2365341A1 (fr) Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
BE859846A (fr) Nouveaux derives d'acide alpha-thio-alcanoique
BE864321A (fr) Derives d'acide oxazolinoazetidinylbutyrique
BE848023A (fr) Nouveaux derives de l'acide phosphorique,
BE810652A (fr) Purification de l'acide phosphorique
BE852313A (fr) Nouveaux derives d'acide 4,5-dichlorimidazole-2-carboxylique
BE811209A (fr) Nouveaux derives de l'acide phenylacetique
BE852172A (fr) Nouveaux derives de l'acide pyridil-phosphorique
FR2352818A1 (fr) Nouveaux derives de l'acide 6'-amino-spiro(cycloalkane-1,2'-penam)-3'-carboxylique
FI803038A7 (fi) 2,5-diketoglukonihapon valmistus.
FR2377406A1 (fr) Composes de tetrathiapentalene et de tetraselenapentalene
PT68159A (fr) Procede de preparation de nouveaux derives de l'acide piperazinecarbodithioique
BE866900A (fr) Derives de l'acide 2-trichloromethyl-4-nitrobenzenesulfenique
BE862267A (fr) Purification de l'acide phosphorique